FDA Adverse Event
Injury
Summary report: N
SEALPTFE VASCULAR GRAFT
MDR report key: 1832193
·
Received September 3, 2010
Report
- Report Number
- MW5017342
- Event Type
- Injury
- Date Received
- September 3, 2010
- Date of Event
- September 3, 2010
- Report Date
- September 3, 2010
- Manufacturer
- VASCUTEK
- Product Code
- DSY
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
Narratives
Description of Event or Problem · 1
PATIENT HAS END STAGE RENAL DISEASE AND UNDERSENT IMPLANTATION OF GELATIN SEALED PTFE DIALYSIS GRAFT (B)(6)2010. POSTOP SHE HAD MORE SWELLING THAN EXPECTED AND FLUID AROUND THE GRAFT. SHE WAS READMITTED WITH INFECTED PTFE GRAFT WHICH WAS EXPLANTED (B)(6)2010. DATES OF USE: (B)(6)2010 -- (B)(6)2010. DIAGNOSIS OR REASON FOR USE: DIALYSIS ACCESS. EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED?: YES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SEALPTFE VASCULAR GRAFT | GELATIN SEALED VASCULAR GRAFT | DSY | VASCUTEK | #P1931-1A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Hospitalization| L |